 | • レポートコード：MRC23Q36400 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の膨張歯茎治療市場について調査・分析し、世界の膨張歯茎治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、OraPharma、Sunstar Group、Hainan Jianke Pharmaceutical、Shenzhen Nanyue Pharmaceutical、Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.、Lion Corporation、GlaxoSmithKline、Colgate、Procter & Gamble、CREST、Novartis、Teva Pharmaceutical、Mylan、Sanofi、Merck、Otsuka Pharmaceutical、Abbott Laboratories、Eli Lilly and Company、Hindustan Antibioticsなどが含まれています。世界の膨張歯茎治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、膨張歯茎治療市場規模を推定する際に考慮しました。本レポートは、膨張歯茎治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、膨張歯茎治療に関するビジネス上の意思決定に役立てることを目的としています。 ・膨張歯茎治療市場の概要 - 膨張歯茎治療のタイプ別セグメント - 世界の膨張歯茎治療市場規模：タイプ別分析（ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン） - 膨張歯茎治療の用途別セグメント - 世界の膨張歯茎治療市場規模：用途別分析（病院、薬局、その他） - 世界の膨張歯茎治療市場規模予測（2018年-2029年） ・膨張歯茎治療市場の成長トレンド - 膨張歯茎治療の地域別市場規模（2018年-2029年） - 膨張歯茎治療市場ダイナミクス - 膨張歯茎治療の業界動向 - 膨張歯茎治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン - 世界の膨張歯茎治療のタイプ別市場規模（2018年-2023年） - 世界の膨張歯茎治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、薬局、その他 - 世界の膨張歯茎治療の用途別市場規模（2018年-2023年） - 世界の膨張歯茎治療の用途別市場規模（2024年-2029年） ・膨張歯茎治療の地域別市場規模 - 北米の膨張歯茎治療市場規模（2018年-2029年） - アメリカの膨張歯茎治療市場規模（2018年-2029年） - ヨーロッパの膨張歯茎治療市場規模（2018年-2029年） - アジア太平洋の膨張歯茎治療市場規模（2018年-2029年） - 中国の膨張歯茎治療市場規模（2018年-2029年） - 日本の膨張歯茎治療市場規模（2018年-2029年） - 韓国の膨張歯茎治療市場規模（2018年-2029年） - インドの膨張歯茎治療市場規模（2018年-2029年） - オーストラリアの膨張歯茎治療市場規模（2018年-2029年） - 中南米の膨張歯茎治療市場規模（2018年-2029年） - 中東・アフリカの膨張歯茎治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 OraPharma、Sunstar Group、Hainan Jianke Pharmaceutical、Shenzhen Nanyue Pharmaceutical、Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.、Lion Corporation、GlaxoSmithKline、Colgate、Procter & Gamble、CREST、Novartis、Teva Pharmaceutical、Mylan、Sanofi、Merck、Otsuka Pharmaceutical、Abbott Laboratories、Eli Lilly and Company、Hindustan Antibiotics ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Swollen Gum Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Swollen Gum Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Swollen Gum Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Swollen Gum Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Swollen Gum Treatment include OraPharma, Sunstar Group, Hainan Jianke Pharmaceutical, Shenzhen Nanyue Pharmaceutical, Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd., Lion Corporation, GlaxoSmithKline, Colgate and Procter & Gamble, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swollen Gum Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swollen Gum Treatment.
The Swollen Gum Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Swollen Gum Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swollen Gum Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
OraPharma
Sunstar Group
Hainan Jianke Pharmaceutical
Shenzhen Nanyue Pharmaceutical
Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.
Lion Corporation
GlaxoSmithKline
Colgate
Procter & Gamble
CREST
Novartis
Teva Pharmaceutical
Mylan
Sanofi
Merck
Otsuka Pharmaceutical
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Segment by Type
Minocycline
Chlorhexidine
Iodine Glycerin
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swollen Gum Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Swollen Gum Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Minocycline
1.2.3 Chlorhexidine
1.2.4 Iodine Glycerin
1.3 Market by Application
1.3.1 Global Swollen Gum Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swollen Gum Treatment Market Perspective (2018-2029)
2.2 Swollen Gum Treatment Growth Trends by Region
2.2.1 Global Swollen Gum Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Swollen Gum Treatment Historic Market Size by Region (2018-2023)
2.2.3 Swollen Gum Treatment Forecasted Market Size by Region (2024-2029)
2.3 Swollen Gum Treatment Market Dynamics
2.3.1 Swollen Gum Treatment Industry Trends
2.3.2 Swollen Gum Treatment Market Drivers
2.3.3 Swollen Gum Treatment Market Challenges
2.3.4 Swollen Gum Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swollen Gum Treatment Players by Revenue
3.1.1 Global Top Swollen Gum Treatment Players by Revenue (2018-2023)
3.1.2 Global Swollen Gum Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Swollen Gum Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Swollen Gum Treatment Revenue
3.4 Global Swollen Gum Treatment Market Concentration Ratio
3.4.1 Global Swollen Gum Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swollen Gum Treatment Revenue in 2022
3.5 Swollen Gum Treatment Key Players Head office and Area Served
3.6 Key Players Swollen Gum Treatment Product Solution and Service
3.7 Date of Enter into Swollen Gum Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Swollen Gum Treatment Breakdown Data by Type
4.1 Global Swollen Gum Treatment Historic Market Size by Type (2018-2023)
4.2 Global Swollen Gum Treatment Forecasted Market Size by Type (2024-2029)
5 Swollen Gum Treatment Breakdown Data by Application
5.1 Global Swollen Gum Treatment Historic Market Size by Application (2018-2023)
5.2 Global Swollen Gum Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Swollen Gum Treatment Market Size (2018-2029)
6.2 North America Swollen Gum Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Swollen Gum Treatment Market Size by Country (2018-2023)
6.4 North America Swollen Gum Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swollen Gum Treatment Market Size (2018-2029)
7.2 Europe Swollen Gum Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Swollen Gum Treatment Market Size by Country (2018-2023)
7.4 Europe Swollen Gum Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swollen Gum Treatment Market Size (2018-2029)
8.2 Asia-Pacific Swollen Gum Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Swollen Gum Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Swollen Gum Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swollen Gum Treatment Market Size (2018-2029)
9.2 Latin America Swollen Gum Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Swollen Gum Treatment Market Size by Country (2018-2023)
9.4 Latin America Swollen Gum Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swollen Gum Treatment Market Size (2018-2029)
10.2 Middle East & Africa Swollen Gum Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Swollen Gum Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Swollen Gum Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OraPharma
11.1.1 OraPharma Company Detail
11.1.2 OraPharma Business Overview
11.1.3 OraPharma Swollen Gum Treatment Introduction
11.1.4 OraPharma Revenue in Swollen Gum Treatment Business (2018-2023)
11.1.5 OraPharma Recent Development
11.2 Sunstar Group
11.2.1 Sunstar Group Company Detail
11.2.2 Sunstar Group Business Overview
11.2.3 Sunstar Group Swollen Gum Treatment Introduction
11.2.4 Sunstar Group Revenue in Swollen Gum Treatment Business (2018-2023)
11.2.5 Sunstar Group Recent Development
11.3 Hainan Jianke Pharmaceutical
11.3.1 Hainan Jianke Pharmaceutical Company Detail
11.3.2 Hainan Jianke Pharmaceutical Business Overview
11.3.3 Hainan Jianke Pharmaceutical Swollen Gum Treatment Introduction
11.3.4 Hainan Jianke Pharmaceutical Revenue in Swollen Gum Treatment Business (2018-2023)
11.3.5 Hainan Jianke Pharmaceutical Recent Development
11.4 Shenzhen Nanyue Pharmaceutical
11.4.1 Shenzhen Nanyue Pharmaceutical Company Detail
11.4.2 Shenzhen Nanyue Pharmaceutical Business Overview
11.4.3 Shenzhen Nanyue Pharmaceutical Swollen Gum Treatment Introduction
11.4.4 Shenzhen Nanyue Pharmaceutical Revenue in Swollen Gum Treatment Business (2018-2023)
11.4.5 Shenzhen Nanyue Pharmaceutical Recent Development
11.5 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.
11.5.1 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Company Detail
11.5.2 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Business Overview
11.5.3 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Swollen Gum Treatment Introduction
11.5.4 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue in Swollen Gum Treatment Business (2018-2023)
11.5.5 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Recent Development
11.6 Lion Corporation
11.6.1 Lion Corporation Company Detail
11.6.2 Lion Corporation Business Overview
11.6.3 Lion Corporation Swollen Gum Treatment Introduction
11.6.4 Lion Corporation Revenue in Swollen Gum Treatment Business (2018-2023)
11.6.5 Lion Corporation Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Swollen Gum Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Swollen Gum Treatment Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Colgate
11.8.1 Colgate Company Detail
11.8.2 Colgate Business Overview
11.8.3 Colgate Swollen Gum Treatment Introduction
11.8.4 Colgate Revenue in Swollen Gum Treatment Business (2018-2023)
11.8.5 Colgate Recent Development
11.9 Procter & Gamble
11.9.1 Procter & Gamble Company Detail
11.9.2 Procter & Gamble Business Overview
11.9.3 Procter & Gamble Swollen Gum Treatment Introduction
11.9.4 Procter & Gamble Revenue in Swollen Gum Treatment Business (2018-2023)
11.9.5 Procter & Gamble Recent Development
11.10 CREST
11.10.1 CREST Company Detail
11.10.2 CREST Business Overview
11.10.3 CREST Swollen Gum Treatment Introduction
11.10.4 CREST Revenue in Swollen Gum Treatment Business (2018-2023)
11.10.5 CREST Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Swollen Gum Treatment Introduction
11.11.4 Novartis Revenue in Swollen Gum Treatment Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Teva Pharmaceutical
11.12.1 Teva Pharmaceutical Company Detail
11.12.2 Teva Pharmaceutical Business Overview
11.12.3 Teva Pharmaceutical Swollen Gum Treatment Introduction
11.12.4 Teva Pharmaceutical Revenue in Swollen Gum Treatment Business (2018-2023)
11.12.5 Teva Pharmaceutical Recent Development
11.13 Mylan
11.13.1 Mylan Company Detail
11.13.2 Mylan Business Overview
11.13.3 Mylan Swollen Gum Treatment Introduction
11.13.4 Mylan Revenue in Swollen Gum Treatment Business (2018-2023)
11.13.5 Mylan Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Swollen Gum Treatment Introduction
11.14.4 Sanofi Revenue in Swollen Gum Treatment Business (2018-2023)
11.14.5 Sanofi Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck Swollen Gum Treatment Introduction
11.15.4 Merck Revenue in Swollen Gum Treatment Business (2018-2023)
11.15.5 Merck Recent Development
11.16 Otsuka Pharmaceutical
11.16.1 Otsuka Pharmaceutical Company Detail
11.16.2 Otsuka Pharmaceutical Business Overview
11.16.3 Otsuka Pharmaceutical Swollen Gum Treatment Introduction
11.16.4 Otsuka Pharmaceutical Revenue in Swollen Gum Treatment Business (2018-2023)
11.16.5 Otsuka Pharmaceutical Recent Development
11.17 Abbott Laboratories
11.17.1 Abbott Laboratories Company Detail
11.17.2 Abbott Laboratories Business Overview
11.17.3 Abbott Laboratories Swollen Gum Treatment Introduction
11.17.4 Abbott Laboratories Revenue in Swollen Gum Treatment Business (2018-2023)
11.17.5 Abbott Laboratories Recent Development
11.18 Eli Lilly and Company
11.18.1 Eli Lilly and Company Company Detail
11.18.2 Eli Lilly and Company Business Overview
11.18.3 Eli Lilly and Company Swollen Gum Treatment Introduction
11.18.4 Eli Lilly and Company Revenue in Swollen Gum Treatment Business (2018-2023)
11.18.5 Eli Lilly and Company Recent Development
11.19 Hindustan Antibiotics
11.19.1 Hindustan Antibiotics Company Detail
11.19.2 Hindustan Antibiotics Business Overview
11.19.3 Hindustan Antibiotics Swollen Gum Treatment Introduction
11.19.4 Hindustan Antibiotics Revenue in Swollen Gum Treatment Business (2018-2023)
11.19.5 Hindustan Antibiotics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details